Comparative Studies on Interactions of Synthetic and Natural Compounds with Hen Egg-White Lysozyme

Amyloid aggregation of polypeptides is related to a
growing number of pathologic states known as amyloid disorders. In
recent years, blocking or reversing amyloid aggregation via the use of
small compounds are considered as two useful approaches in
hampering the development of these diseases. In this research, we
have compared the ability of several manganese-salen derivatives, as
synthetic compounds, and apigenin, as a natural flavonoid, to inhibit
of hen egg-white lysozyme (HEWL) aggregation, as an in vitro
model system.
Different spectroscopic analyses such as Thioflavin T (ThT) and
Anilinonaphthalene-8-sulfonic acid (ANS) fluorescence, Congo red
(CR) absorbance along with transmission electron microscopy were
used in this work to monitor the HEWL aggregation kinetic and
inhibition. Our results demonstrated that both type of compounds
were capable to prevent the formation of lysozyme amyloid
aggregation in vitro. In addition, our data indicated that synthetic
compounds had higher activity to inhibit of the β-sheet structures
relative to natural compound. Regarding the higher antioxidant
activities of the salen derivatives, it can be concluded that in addition
to aromatic rings of each of the compounds, the potent antioxidant
properties of salen derivatives contributes to lower lysozyme fibril
accumulation.





References:
[1] C.M. Dobson, "Protein misfolding, evolution and disease”, Trends in
biochemical sciences. vol. 24, pp. 329-332, 1999.
[2] E.H. Koo, P.T. Lansbury, J.W. Kelly, "Amyloid diseases: abnormal
protein aggregation in neurodegeneration”, Proceedings of the National
Academy of Sciences of the United States of America.vol. 96, pp. 9989-
9990, 1999.
[3] Z. Gazova, A. Bellova, Z. Daxnerova, J. Imrich, P. Kristian, J.
Tomascikova, J. Bagelova, D. Fedunova, M. Antalik, "Acridine
derivatives inhibit lysozyme aggregation”, European biophysics
journal,. vol. 37, pp. 1261-1270, 2008.
[4] C.M. Dobson, "The structural basis of protein folding and its links with
human disease”, Philosophical transactions of the Royal Society of
London. Series B, Biological sciences,vol. 356, pp. 133-145, 2001.
[5] C.A. Ross, M.A. Poirier, "Protein aggregation and neurodegenerative
disease”, Nature Medicine,Vol. 10, (Suppl) S10-S17, 2004.
[6] L.C. Serpell, M. Sunde, M.D. Benson, G.A. Tennent, M.B. Pepys, P.E.
Fraser, "The protofilament substructure of amyloid fibrils”, Journal of
Molecular Biology, Vol. 300, pp.1033-1039,2000.
[7] M.N.N. Vieira, J.D. Figueroa-Villar, M.N.L. Meirelles, S.T. Ferreira,
F.G. De Felice, "Small Molecule Inhibitors of Lysozyme Amyloid
Aggregation”, Cell Biochemistry and Biophysics,Vol. 44, pp. 549-553,
2006.
[8] L.N. Arnaudov, R. de Vries, Thermally induced fibrillar aggregation of
Hen Egg White Lysozyme, Biophysical Journal, vol. 88, pp. 515-526,
2005.
[9] Y. Porat, A. Abramowitz, E. Gazit, "Inhibition of amyloid fibril
formation by polyphenols: structural similarity and aromatic interactions
as a common inhibition mechanism”, Chemical Biology & Drug Design,
Vol. 67,pp. 27-37, 2006.
[10] M. Baudry, S. Etienne, A. Bruce, M. Palucki, E. Jacobsen, B. Malfroy,
"Salen–manganese complexes are superoxide dismutase mimics”,
Biochemical and biophysical research communications,Vol. 192, pp.
964-968, 1993.
[11] M.R. Nilsson, "Techniques to study amyloid fibril formation in vitro”,
Methods, vol. 34, no. 1, pp. 151-160, 2004.
[12] A. Rabiee, A. Ebrahim-Habibi, L. Navidpour, D. Morshedi, A. Ghasemi,
M. Sabbaghian, M. Nemati-Lay, M. Nemat-Gorgani, "Benzofuranone
Derivatives as Effective Small Molecules Related to Insulin Amyloid
Fibrillation: A Structure-Function Study”, Chemical Biology & Drug
Design, vol. 78, pp. 659-666, 2011.
[13] J.H. Byun, H. Kim, Y. Kim, I. Mook-Jung, D.J. Kim, W.K. Lee, K.H.
Yoo, "Aminostyrylbenzofuran derivatives as potent inhibitors for Abeta
fibril formation”, Bioorganic and Medicinal Chemistry Letter,Vol.
18,pp. 5591-5593, 2008.